Endoscopic salpingectomy.
Tarasconi JC.
J Reprod Med. 1981 Oct;26(10):541-5.
Completeness of salpingectomy intended for ovarian cancer risk reduction.
Wong JWH, Killeen JL, Carney ME.
Gynecol Oncol. 2019 Nov;155(2):280-282. doi: 10.1016/j.ygyno.2019.09.005. Epub 2019 Sep 12.
Effective thermal destruction of residual tubal epithelium using an advanced sealing device in opportunistic salpingectomy: A randomized trial.
Choi HJ, Kim HS, Kim TJ, Song SY, Paik ES, Jin Heo E, Park JY, Lee YY, Choi CH, Lee JW, Kim BG, Bae DS.
Gynecol Minim Invasive Ther. 2017 Jul-Sep;6(3):108-112. doi: 10.1016/j.gmit.2016.12.005. Epub 2017 Feb 8.
Persistence of fimbrial tissue on the ovarian surface after salpingectomy.
Gan C, Chenoy R, Chandrasekaran D, Brockbank E, Hollingworth A, Vimplis S, Lawrence AC, Jeyarajah AR, Oram D, Deo N, Saravanamuthu J, Lam SS, Faruqi A, Singh N, Manchanda R.
Am J Obstet Gynecol. 2017 Oct;217(4):425.e1-425.e16. doi: 10.1016/j.ajog.2017.06.004. Epub 2017 Jun 10.
The uterine adenosarcoma with postoperative residual in a woman treated by total abdominal hysterectomy/bilateral salpingo-oophorectomy: A case report and review of literature.
Fadavi P, Garousi M, Soltani S, Montazer F, Abolhasani M, Asgari S, Mirzaee E.
Cancer Rep (Hoboken). 2023 Oct;6(10):e1891. doi: 10.1002/cnr2.1891. Epub 2023 Aug 17.
Risk of Peritoneal Carcinomatosis After Risk-Reducing Salpingo-Oophorectomy: A Systematic Review and Individual Patient Data Meta-Analysis.
Steenbeek MP, van Bommel MHD, Bulten J, Hulsmann JA, Bogaerts J, Garcia C, Cun HT, Lu KH, van Beekhuizen HJ, Minig L, Gaarenstroom KN, Nobbenhuis M, Krajc M, Rudaitis V, Norquist BM, Swisher EM, Mourits MJE, Massuger LFAG, Hoogerbrugge N, Hermens RPMG, IntHout J, de Hullu JA.
J Clin Oncol. 2022 Jun 10;40(17):1879-1891. doi: 10.1200/JCO.21.02016. Epub 2022 Mar 18.
Management of a uterine serosal heterotopic pregnancy after in vitro fertilization in a woman with bilateral salpingectomy: A case report and literature review.
Sun PP, Dong SY, Xie JL, Liu KK, Guo AP.
Medicine (Baltimore). 2022 Dec 23;101(51):e32551. doi: 10.1097/MD.0000000000032551.
Cancer of the corpus uteri.
Amant F, Mirza MR, Koskas M, Creutzberg CL.
Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:37-50. doi: 10.1002/ijgo.12612.
Complete tubal abortion which didn't require salpingectomy.
Zapletal J, Maxová K, Halaška MJ, Rob L, Hruda M.
Ceska Gynekol. 2024;89(3):210-214. doi: 10.48095/cccg2024210.
Occult residual ovarian tissue at the time of minimally invasive risk reducing surgery in women with BRCA mutations.
Polan RM, Ali-Fehmi R, Grace AK, Mattei LH, Tanner EJ 3rd, Morris RT.
Gynecol Oncol. 2024 Oct;189:37-40. doi: 10.1016/j.ygyno.2024.07.005. Epub 2024 Jul 15.
